
Jonathan Nahmany

Equasens maintains positive momentum in 2025
The specialist in digital solutions for healthcare professionals reported solid growth in its 2025 results, driven by strong performance across its portfolio of solutions for practitioners and healthcare facilities. Revenue reached EUR 236.5 million, up 9.1%.
March 30, 2026 at 02:40 am

Dékuple confirms growth momentum
The communication and data marketing specialist recorded sustained growth in 2025, with revenue reaching 242.6 million euros, up 11.4%. Net income (gross margin) stood at 180.5 million euros, a 6.8% increase, reflecting the resilience of its business model in a persistently challenging environment.
March 30, 2026 at 02:28 am

Vente-unique.com
CAFOM has announced the sale of the Habitat brands to its subsidiary Vente-unique.com for 11 million euros, a move that marks a new milestone in the online furniture retailer's premiumization strategy. Already operated under license since April 2024, the Habitat brand was successfully relaunched by Vente-unique.com, generating 10 million euros in revenue during its first fiscal year ended September 30, 2025.
March 30, 2026 at 02:19 am

CAFOM sells Habitat to Vente-unique.com for 11 million euros
CAFOM has announced the sale of the Habitat brands to its subsidiary Vente-unique.com for 11 million euros, a move that marks a new milestone in the online furniture specialist's upmarket strategy. Already operated under license since April 2024, the Habitat brand was successfully relaunched by Vente-unique.com, generating 10 million euros in revenue during its first fiscal year ended September 30, 2025.
March 30, 2026 at 02:17 am

Thales
Thales announced on Saturday the successful launch of two satellites as part of the European Space Agency's (ESA) Celeste in-orbit demonstration mission. One of these, designated IOD-2, was developed by Thales Alenia Space, the joint venture between Thales and Leonardo.
March 30, 2026 at 02:09 am
European equities retreat; Pernod Ricard gains ground
On the 28th day of the Persian Gulf conflict, European equity markets are trading in the red amid geopolitical uncertainty. The CAC 40 is down 1.06% at 7,686 points, while the Euro Stoxx 50 has shed 1.31% to 5,492 points.
March 27, 2026 at 07:18 am

GenSight Biologics
The biopharmaceutical company reached a pivotal milestone in 2025, marked by significant regulatory progress that establishes a solid foundation for 2026. Against this backdrop, the company estimates that its cash runway is now secured through December 2026.
March 27, 2026 at 03:37 am

GenSight Biologics: Cash Runway Secured Through Year-End 2026
The biopharmaceutical company reached a pivotal milestone in 2025, marked by significant regulatory progress that establishes a solid foundation for 2026. Against this backdrop, the company estimates that its cash runway is now secured until December 2026.
March 27, 2026 at 03:34 am

Reworld Media shares tumble following 2025 results
The media group's stock is down nearly 7% this morning following the release of its annual accounts. The company reported consolidated revenue of 529.3 million euros for 2025, a 1% decline. However, EBITDA rose by 3% to 55.4 million euros, bringing the margin to 10.5%, while group net income fell by 27.5% to 16.9 million euros.
March 26, 2026 at 05:41 am
Discover our authors
Chief Editor
Journalist
Journalist
Journalist
Journalist
- Stock Market
- Our authors
- Jonathan Nahmany

























